Impax Asset Management Group »

Chemours shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Chemours (CC) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Chemours

Tip: Access up to 7 years of quarterly data

All positions including Chemours held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemours by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $611k 22k 28.05
2023-06-30 $818k 22k 36.89
2023-03-31 $1.2M 41k 29.94
2022-12-31 $2.1M 70k 30.62
2022-09-30 $1.8M 73k 24.66
2022-06-30 $297k 9.4k 31.47
2022-03-31 $297k 9.4k 31.47
2021-12-31 $318k 9.5k 33.53
2021-09-30 $283k 9.7k 29.04
2021-06-30 $339k 9.7k 34.79
2021-03-31 $272k 9.7k 27.91

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Veralto Corp Common Stock (VLTO)
Hubbell Common Stock (HUBB)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Agilent Technologies Common Stock (A)
A O Smith Corp Common Stock (AOS)
Advanced Drainage Systems Common Stock (WMS)
IDEX Corp Common Stock (IEX)
RenaissanceRe Holdings Common Stock (RNR)
Synopsys Common Stock (SNPS)
Marvell Technology Common Stock (MRVL)

View all positions for Impax Asset Management Group

Top funds holding Chemours

BlackRock
Vanguard Group
State Street Corporation
Ameriprise Financial
UBS Group
Jpmorgan Chase & Co
Millennium Management
FMR
Cooper Creek Partners Management
Geode Capital Management
Scopia Management
Goldman Sachs Group
American Century Companies
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Chemours